https://trial-in.com/glioblastoma/glioblastoma-gbm-vt1021-demonstrates-promising-results/
Glioblastoma (GBM) - VT1021 Demonstrates Promising Results - TRIAL-IN Pharma
Feb 28, 2022 - VT1021 is a targeted therapy drug that helps with several types of cancer, including advanced cases of Glioblastoma, GBM. The results are quite promising.
promising resultsglioblastomagbmdemonstratestrial